Dr. Alessandra Martinelli and her colleagues from the School of Science and Technology in Brazil, evaluated the spatial variables of gait and isometric muscle strength in patients with diabetic peripheral neuropathy. They found that the ankle, muscle strength, and ankle mobility variables could explain differences differences in gait speed and range of motion. READ MORE …
Results of a randomized controlled clinical trial are being published to report on the effects of weight-bearing versus non-weight-bearing exercise for people with diabetic peripheral neuropathy. Participants were recruited from a university-based physical therapy clinic. A relatively small study group had six-minute walk distance and daily step counts measured for 12 weeks, with the weight-bearing …
A new drug therapy, nabilone, has been tested at University of Calgary’s Hotchkiss Brain Institute. At the end of the study, patients reported less pain and an improvement in sleep and anxiety when taking nabilone. The drug is currently used in Canada to treat nausea in chemotherapy patients. Nabilone is a synthetic cannabinoid, which mimics some …
Drug Offers New Pain Management Therapy for Diabetics Read More »
Dr. Charles E. Argoff, Albany (NY) Medical Center, discussed diabetic peripheral neuropathy at PAINWeek 2012. He provided instruction in how to recognize and treat DPN. Quality of life is heavily impacted by DPN and there is increased medication and burden on the healthcare system, with a cost of up to $13.7 billion dollars annually. Dr. …
Recognizing and Treating Diabetic Peripheral Neuropathy Read More »
Julia Boyle, PhD., University of Surrey (UK), and colleagues conducted a study of Type 1 and Type 2 diabetics with chronic painful DPN taking common medications to treat DPN: amitryptiline (Elavil), duloxetine (Cymbalta), and pregabalin (Lyrica). Their goal was to assess the impact of these medications on pain, sleep, daytime functioning, and quality of life. …
Drugs Similar in Efficacy for Neuropathic Pain in Diabetes Read More »
Janssen Pharmaceuticals, Inc. announced the FDA has approved the supplemental New Drug Application for NUCYNTA ER extended-release tables for the management of neuropathic pain associated with diabetic peripheral neuropathy. NUCYNTA ER is the first and only opioid approved by the FDA for this purpose. “Pain from DPN can be difficult to manage, leaving some patients …
FDA Approves NUCYNTA ER Extended Release Oral Tablets Read More »
The American Chronic Pain Society joined with Pfizer to conduct a survey on the prevalence of symptoms of diabetic peripheral neuropathy in patients with diabetes. Their results show that nerve pain is reported in about twice as many patients as estimated by healthcare providers. Additionally, the survey found gaps in communication between doctors, nurses, and …
Diabetic Nerve Pain More Common Than Doctors Think Read More »
New study has been published showing the potential of stem cells providing relief to people suffering from painful diabetic peripheral neuropathy (DPN). Stem Cells Translational Medicine published the study on July 9th. Inflammation is considered a major culprit in DPN. While there are treatments for the diabetes and to helping to alleviate pain, Dr. Ruth …
New Type of Stem Cell Preparation Could Bring Pain Relief to Diabetics Read More »
Researchers at the University of New South Wales have new reserach that may lead to new therapeutic approaches for treating patients with diabetic neuropathy, reported Professor Matthew Kiernan in Diabetes. They tested nerve excitability in diabetics and found that those without irreversible nerve damage still showed excitability abnormalities well before the development of clinical symptoms. READ MORE from …
Potential Biomarker Emerging for Diabetic Neuropathy Read More »
A systematic review of enhanced glucose control, studied at the University of Michigan and reported in The Cochrane Library, suggests that it is possible to prevent neuropathy by strict control of blood sugar levels, including different insulin regimens and diet modification. Dr. Brian Callaghan, MD, Assistant Professor of Neurology, indicated that, “this evidence suggests that …
Tighter Control of Blood Sugar Prevents Nerve Condition but at What Risk? Read More »
